Pryidostigmine Bromide
NDC Package 73152-028-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Pryidostigmine Bromide is pyridostigmine bromide oral solution is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. Marketed by Athem Llc, this product is identified by NDC 73152-028 and is authorized under FDA application ANDA208797.

Identification & Billing

NDC Package Code
73152-028-16
Package Description
473 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
73152002816
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pryidostigmine Bromide
Dosage Form
-
Usage Information
Pyridostigmine bromide oral solution is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. Care should be observed in the use of atropine for counteracting side effects, as discussed below.

Regulatory & Marketing

Labeler Name
Athem Llc
FDA Application #
ANDA208797
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-25-2021
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73152-028-16 identifies a specific commercial package of 473 ml in 1 bottle, plastic of Pryidostigmine Bromide, labeled by Athem Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Athem Llc on February 25, 2021. The current certification is valid through December 31, 2025.

How is this Athem Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73152002816. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73152-028-16
11-Digit CMS (5-4-2)
73152-0028-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.